Masimo 'disappointed' in Q2 results, confirms slashed guidance
Masimo shares fell this morning after the company shared second-quarter results that included slashed 2023 guidance.
Stay updated with breaking news from Massdevice Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Masimo shares fell this morning after the company shared second-quarter results that included slashed 2023 guidance.
Embecta (Nasdaq:EMBC) this morning increased its full-year guidance and shared an update on its automated insulin delivery technology.
Henry Schein (Nasdaq: HSIC) shares fell this morning on second-quarter results that came in mixed compared to the consensus forecast.
IRhythm shares rose after hours today on second-quarter results that topped the consensus forecast.
ResMed shares dropped today on fourth-quarter sales and profits that missed Wall Street's expectations.